Variant report
Variant | esv1797770 |
---|---|
Chromosome Location | chr4:74645716-74660393 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr4:74650823-74650977 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr4:74646568-74646704 | HepG2 | liver: | n/a | chr4:74646632-74646643 chr4:74646630-74646641 chr4:74646632-74646641 chr4:74646630-74646643 |
3 | CHD1 | chr4:74648722-74648747 | GM12878 | blood: | n/a | n/a |
4 | FOS | chr4:74651465-74651478 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOSL2 | chr4:74651268-74651613 | SK-N-SH | brain: | n/a | n/a |
6 | GATA3 | chr4:74651283-74651746 | SK-N-SH | brain: | n/a | n/a |
7 | GATA3 | chr4:74651260-74651743 | SK-N-SH | brain: | n/a | n/a |
8 | IRF1 | chr4:74656593-74656742 | K562 | blood: | n/a | n/a |
9 | JUND | chr4:74651257-74651676 | SK-N-SH | brain: | n/a | n/a |
10 | NFIC | chr4:74651236-74651708 | SK-N-SH | brain: | n/a | n/a |
11 | PBX3 | chr4:74651257-74651622 | SK-N-SH | brain: | n/a | n/a |
12 | PBX3 | chr4:74651263-74651611 | SK-N-SH | brain: | n/a | n/a |
13 | TCF12 | chr4:74651253-74651715 | SK-N-SH | brain: | n/a | n/a |
14 | YY1 | chr4:74651312-74651573 | SK-N-SH_RA | brain: | n/a | n/a |
15 | ZNF263 | chr4:74653682-74654405 | HEK293-T-REx | kidney: | n/a | chr4:74653959-74653980 chr4:74654028-74654049 |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:74645799..74647347-chr4:74650995..74652534,2 | K562 | blood: | |
2 | chr4:74548490..74550703-chr4:74648788..74651649,2 | K562 | blood: | |
3 | chr4:74646058..74648383-chr4:74648507..74650291,2 | K562 | blood: | |
4 | chr4:74620363..74622563-chr4:74652103..74654491,2 | K562 | blood: | |
5 | chr4:74646058..74648383-chr4:74648507..74650291,2 | K562 | blood: | |
6 | chr4:74645799..74647347-chr4:74650995..74652534,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249051 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7668660 | chr4:74645716-74645717 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs563611308 | chr4:74645738-74645739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs180997964 | chr4:74645750-74645751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549452986 | chr4:74645773-74645774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185113219 | chr4:74645784-74645785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535715584 | chr4:74645803-74645804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568608426 | chr4:74645810-74645811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190783296 | chr4:74645852-74645853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546661624 | chr4:74645875-74645876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571383050 | chr4:74645876-74645877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538612540 | chr4:74645929-74645930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568357734 | chr4:74645955-74645956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs28833215 | chr4:74646006-74646007 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs75079591 | chr4:74646015-74646016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72650824 | chr4:74646061-74646062 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs116215993 | chr4:74646086-74646087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539585806 | chr4:74646169-74646170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143137615 | chr4:74646175-74646176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533814761 | chr4:74646190-74646191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558871604 | chr4:74646197-74646198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77722254 | chr4:74646225-74646226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115368816 | chr4:74646247-74646248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2224434 | chr4:74646315-74646316 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs544961648 | chr4:74646371-74646372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs148258103 | chr4:74646394-74646395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184111539 | chr4:74646396-74646397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554055089 | chr4:74646419-74646420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565888640 | chr4:74646459-74646460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561462151 | chr4:74646464-74646465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528653761 | chr4:74646487-74646488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546902513 | chr4:74646506-74646507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141257642 | chr4:74646507-74646508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75611546 | chr4:74646515-74646516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539867830 | chr4:74646549-74646550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550733618 | chr4:74646565-74646566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555751748 | chr4:74646601-74646602 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs2145617 | chr4:74646615-74646616 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs186690619 | chr4:74646643-74646644 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs13149816 | chr4:74646674-74646675 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs374802222 | chr4:74646745-74646746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150806043 | chr4:74646781-74646782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115354673 | chr4:74646806-74646807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576668944 | chr4:74646816-74646817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538743877 | chr4:74646823-74646824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs118009110 | chr4:74646843-74646844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138189014 | chr4:74646845-74646846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192000878 | chr4:74646852-74646853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs77386641 | chr4:74646859-74646860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113487530 | chr4:74646917-74646918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561600675 | chr4:74646918-74646919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Aortic dissecting aneurysms | 22263138 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:74637200-74646400 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
2 | chr4:74646400-74647000 | Enhancers | Rectal Mucosa Donor 29 | rectum |
3 | chr4:74646400-74647000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
4 | chr4:74646800-74647400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr4:74653200-74655400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr4:74654000-74654800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |